Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Q-linea AB's Enterprise Value is kr99.53 Mil.
Q-linea AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was kr-164.58 Mil. Therefore, Q-linea AB's EV-to-EBIT ratio for today is -0.60.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Q-linea AB's Enterprise Value is kr99.53 Mil.
Q-linea AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was kr-149.70 Mil. Therefore, Q-linea AB's EV-to-EBITDA ratio for today is -0.66.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Q-linea AB's Enterprise Value is kr99.53 Mil.
Q-linea AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was kr9.44 Mil. Therefore, Q-linea AB's EV-to-Revenue ratio for today is 10.54.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Q-linea AB's Enterprise Value is kr99.53 Mil.
Q-linea AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was kr-153.58 Mil. Therefore, Q-linea AB's EV-to-FCF ratio for today is -0.65.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Q-linea AB (FRA:3F80) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Q-linea AB's current Enterprise Value is kr99.53 Mil.
Q-linea AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-164.58 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Q-linea AB's current Enterprise Value is kr99.53 Mil.
Q-linea AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-149.70 Mil.
Q-linea AB's current Enterprise Value is kr99.53 Mil.
Q-linea AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr9.44 Mil.
Q-linea AB's current Enterprise Value is kr99.53 Mil.
Q-linea AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-143.32 Mil.
Q-linea AB's current Enterprise Value is kr99.53 Mil.
Q-linea AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-153.58 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Q-linea AB Enterprise Value Related Terms
Q-linea AB Enterprise Value Historical Data
* Premium members only.
The historical data trend for Q-linea AB's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:3F80 vs ABT, SYK, MDT: Enterprise Value Comparison
For the Medical Devices subindustry, Q-linea AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Q-linea AB Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Q-linea AB's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Q-linea AB's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Q-linea AB's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Q-linea AB (FRA:3F80) has a Enterprise Value of kr99.53 Mil as of Jul. 05, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Q-linea AB and its competitors.
Is Q-linea AB's Enterprise Value too high?
Q-linea AB's current Enterprise Value is kr99.53 Mil. Overall, Q-linea AB has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Q-linea AB's Enterprise Value compare to ABT and SYK?
Q-linea AB's Enterprise Value of kr99.53 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Q-linea AB and its competitors. Q-linea AB's current Enterprise Value is kr99.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-linea AB stock overvalued right now?
Q-linea AB (FRA:3F80) has a current Enterprise Value of kr99.53 Mil. The stock's GF Value™ is kr1.86, compared to a current price of kr1.52 — trading 18.5% below its estimated fair value. The current Enterprise Value is kr99.53 Mil. Q-linea AB's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Q-linea AB (FRA:3F80), the current Enterprise Value is kr99.53 Mil as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Q-linea AB (FRA:3F80) Overvalued in 2026?
Based on GuruFocus' analysis, Q-linea AB stock appears to be undervalued.
The current stock price of kr1.52 is trading 18.5% below its estimated GF Value™ of kr1.86.
Key valuation signals for FRA:3F80:
Enterprise Value: kr99.53 Mil
GF Value™: kr1.86 vs. price of kr1.52 (18.5% below fair value)
No single metric tells the full story. See the FRA:3F80 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
68GF Score
Get the complete analysis for FRA:3F80
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3F80 has been successfully added to your 
